Implementation of a Cost and Variation Reduction Program for Hemostasis Products at a Large Academic Medical Center:...

Area of Science:

• Healthcare Management
• Surgical Supply Chain Optimization
• Health Economics

Background:

• Rising healthcare costs necessitate cost-saving initiatives in surgical supplies management.
• Limited research exists on hospital stakeholder experiences with implementing such cost-saving strategies.
• Understanding stakeholder perspectives is crucial for successful supply chain transitions.

Purpose of the Study:

• To evaluate hospital stakeholder satisfaction with a conversion to a sole supplier for hemostasis products.
• To assess the economic and clinical impacts of this conversion.
• To develop best practices for implementing similar initiatives.

Main Methods:

• A cross-sectional study at a US academic medical center.
• Qualitative interviews and quantitative surveys with clinical and non-clinical stakeholders.
• Analysis of perioperative hemorrhage events, hemostat utilization, and expenditure pre- and post-conversion.

Main Results:

• High stakeholder satisfaction reported, with 75% satisfied with decision-making input and 100% satisfied with the vendor-supported hemostasis optimization program.
• Supply expenditure decreased by nearly 25% post-conversion.
• No significant changes observed in postoperative hemorrhage events, indicating maintained patient care quality.

Conclusions:

• Conversion to a sole vendor for hemostasis products can achieve high stakeholder satisfaction and significant cost savings.
• Successful implementation requires effective coordination between suppliers, institutions, and hospital stakeholders.
• This study offers a roadmap for institutions seeking to optimize hemostasis product management.